# |
Name |
|
Stock Price |
Change |
Price (30 days) | 52W low/high | Sector |
---|
The Clinical Trials company in South Korea with the highest Total Assets is Celltrion, Inc. (KSE: 068270.KS) at USD 14.17 B.
The Clinical Trials company in South Korea with the lowest Total Assets is Oncocross Co., Ltd. (KOSDAQ: 382150.KQ) at None.
The top 10 Clinical Trials companies in South Korea by Total Assets are Celltrion, Inc., Samsung Biologics Co.,Ltd., SD BioSensor, Inc, Yuhan Corporation, Green Cross Holdings Corporation, Green Cross Corporation, Dong-A Socio Holdings Co., Ltd., Hanmi Pharm. Co., Ltd., Daewoong pharmaceutical Co.,Ltd and Chong Kun Dang Holdings Corp..
The bottom 10 Clinical Trials companies in South Korea by Total Assets are Oncocross Co., Ltd., Gencurix Inc., Urban Lithium Inc, MedPacto, Inc., Onconic Therapeutics, Hyundai Bioscience Co., Ltd., OliX Pharmaceuticals,Inc, FutureChem Co.,Ltd, AptaBio Therapeutics Inc. and iNtRON Biotechnology, Inc..